Understanding antimicrobial exposure and Clostridium difficile infection: implications of fluoroquinolone use
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Chicago, IL
Univ. of Chicago Press
2008
|
| Schriftenreihe: | Clinical infectious diseases
Supplement ; 46,1 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | 52 S. Ill., graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV023101032 | ||
| 003 | DE-604 | ||
| 005 | 20080218 | ||
| 007 | t | ||
| 008 | 080128s2008 ad|| |||| 00||| eng d | ||
| 035 | |a (OCoLC)245551188 | ||
| 035 | |a (DE-599)BVBBV023101032 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-19 | ||
| 245 | 1 | 0 | |a Understanding antimicrobial exposure and Clostridium difficile infection |b implications of fluoroquinolone use |c guest ed.: John G. Bartlett ... |
| 264 | 1 | |a Chicago, IL |b Univ. of Chicago Press |c 2008 | |
| 300 | |a 52 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Clinical infectious diseases : Supplement |v 46,1 | |
| 650 | 4 | |a Clostridium difficile | |
| 650 | 4 | |a Clostridium diseases |x Chemotherapy | |
| 650 | 4 | |a Fluoroquinolones |x therapeutic use | |
| 650 | 4 | |a Quinolone antibacterial agents |x Therapeutic use | |
| 700 | 1 | |a Bartlett, John G. |d 1937- |e Sonstige |0 (DE-588)129129585 |4 oth | |
| 830 | 0 | |a Clinical infectious diseases |v Supplement ; 46,1 |w (DE-604)BV004765736 |9 46,1 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016303751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016303751 | ||
Datensatz im Suchindex
| _version_ | 1804137359037431808 |
|---|---|
| adam_text | Clinical Infectioi
UNDERSTANDING ANTIMICROBIAL E)
INFECTION: IMPLICATIONS
SI CME Information
S4 Historical Perspectives on Studies of Clostridium
difficile and C. difficile Infection
John G. Bartlett
SI2 Clinical Recognition and Diagnosis
of Clostridium difficile Infection
John G. Bartlett and Dale N. Gerding
S19 Antimicrobial-Associated Risk Factors
for Clostridium difficile Infection
Robert C. Owens, Jr., Curtis J. Donskey, Robert P. Gaynes,
Vivian G. Loo, and Carlene A. Muto
# 15 January 2008
d-O J XoCd^C^ Supplement 1
(POSURE AND CLOSTRIDIUM DIFFICILE
OF FLUOROQUINOLONE USE
S32 Treatment of Clostridium difficile Infection
Dale N. Gerding, Carlene A Muto, and Robert C Owens, Jr
S43 Measures to Control and Prevent Clostridium
difficile Infection
Dale N. Gerding, Carlene A Muto, and Robert C Owens, Jr
S50 CME Questions
S52 CME Evaluation
|
| adam_txt |
Clinical Infectioi
UNDERSTANDING ANTIMICROBIAL E)
INFECTION: IMPLICATIONS
SI CME Information
S4 Historical Perspectives on Studies of Clostridium
difficile and C. difficile Infection
John G. Bartlett
SI2 Clinical Recognition and Diagnosis
of Clostridium difficile Infection
John G. Bartlett and Dale N. Gerding
S19 Antimicrobial-Associated Risk Factors
for Clostridium difficile Infection
Robert C. Owens, Jr., Curtis J. Donskey, Robert P. Gaynes,
Vivian G. Loo, and Carlene A. Muto
# 15 January 2008
d-O J 'XoCd^C^ Supplement 1
(POSURE AND CLOSTRIDIUM DIFFICILE
OF FLUOROQUINOLONE USE
S32 Treatment of Clostridium difficile Infection
Dale N. Gerding, Carlene A Muto, and Robert C Owens, Jr
S43 Measures to Control and Prevent Clostridium
difficile Infection
Dale N. Gerding, Carlene A Muto, and Robert C Owens, Jr
S50 CME Questions
S52 CME Evaluation |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_GND | (DE-588)129129585 |
| building | Verbundindex |
| bvnumber | BV023101032 |
| ctrlnum | (OCoLC)245551188 (DE-599)BVBBV023101032 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01404nam a2200325 cb4500</leader><controlfield tag="001">BV023101032</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20080218 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080128s2008 ad|| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)245551188</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023101032</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Understanding antimicrobial exposure and Clostridium difficile infection</subfield><subfield code="b">implications of fluoroquinolone use</subfield><subfield code="c">guest ed.: John G. Bartlett ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Chicago, IL</subfield><subfield code="b">Univ. of Chicago Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">52 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Clinical infectious diseases : Supplement</subfield><subfield code="v">46,1</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clostridium difficile</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Clostridium diseases</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fluoroquinolones</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Quinolone antibacterial agents</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bartlett, John G.</subfield><subfield code="d">1937-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)129129585</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Clinical infectious diseases</subfield><subfield code="v">Supplement ; 46,1</subfield><subfield code="w">(DE-604)BV004765736</subfield><subfield code="9">46,1</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016303751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016303751</subfield></datafield></record></collection> |
| id | DE-604.BV023101032 |
| illustrated | Illustrated |
| index_date | 2024-07-02T19:44:43Z |
| indexdate | 2024-07-09T21:11:02Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016303751 |
| oclc_num | 245551188 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | 52 S. Ill., graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Univ. of Chicago Press |
| record_format | marc |
| series | Clinical infectious diseases |
| series2 | Clinical infectious diseases : Supplement |
| spelling | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use guest ed.: John G. Bartlett ... Chicago, IL Univ. of Chicago Press 2008 52 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Clinical infectious diseases : Supplement 46,1 Clostridium difficile Clostridium diseases Chemotherapy Fluoroquinolones therapeutic use Quinolone antibacterial agents Therapeutic use Bartlett, John G. 1937- Sonstige (DE-588)129129585 oth Clinical infectious diseases Supplement ; 46,1 (DE-604)BV004765736 46,1 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016303751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use Clinical infectious diseases Clostridium difficile Clostridium diseases Chemotherapy Fluoroquinolones therapeutic use Quinolone antibacterial agents Therapeutic use |
| title | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use |
| title_auth | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use |
| title_exact_search | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use |
| title_exact_search_txtP | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use |
| title_full | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use guest ed.: John G. Bartlett ... |
| title_fullStr | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use guest ed.: John G. Bartlett ... |
| title_full_unstemmed | Understanding antimicrobial exposure and Clostridium difficile infection implications of fluoroquinolone use guest ed.: John G. Bartlett ... |
| title_short | Understanding antimicrobial exposure and Clostridium difficile infection |
| title_sort | understanding antimicrobial exposure and clostridium difficile infection implications of fluoroquinolone use |
| title_sub | implications of fluoroquinolone use |
| topic | Clostridium difficile Clostridium diseases Chemotherapy Fluoroquinolones therapeutic use Quinolone antibacterial agents Therapeutic use |
| topic_facet | Clostridium difficile Clostridium diseases Chemotherapy Fluoroquinolones therapeutic use Quinolone antibacterial agents Therapeutic use |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016303751&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV004765736 |
| work_keys_str_mv | AT bartlettjohng understandingantimicrobialexposureandclostridiumdifficileinfectionimplicationsoffluoroquinoloneuse |